Biotech is our business

Strategic, insightful and proactive practical support across your product journey. You're in safe hands.

Get In Touch Discover Insights

The Biopharma Excellence team has deep experience with cell and gene therapies and is working hand in hand with us to help realize our ambitious vision.

Where do you need our help?

Developing your drug candidate
Navigating the international regulatory landscape
Getting a new therapy into clinical trials
Applying for marketing authorizations

The Science Huddle

Sign-up for receive a notification when registration is live for the next Science Huddle

Join us on
March 2023

Microscope and slide

Bridging the Biotech / Regulator Divide

 

We help dynamic biopharma companies bring innovative new therapies to market in the smartest, smoothest and safest way possible.

We work closely with biopharma businesses, international regulators and health authorities, and potential investors, to confidently optimize the market potential of cutting-edge biotech innovation.

Our team is a fusion of three scientific powerhouses, Pharmalex, ERA Consulting and Biopharma Excellence – under the PharmaLex brand.  We combine 35+ years of empirical experience and respected regulator relationships.

 

Start-ups

Regulators

Investors

Health Authorities

Biopharma Excellence are pioneers. They’re one of the first ‘recognizable names’ in this industry. They bring entrepreneurial spirit.
Senior Vice President, Pioneer Engineered iPSC
Something that really sets Biopharma Excellence apart is its people. They’re scientists, but much more than that.
Senior Vice President, CMC, Gene Therapy Company
The team at Biopharma Excellence are powerful story-builders and story-tellers. They write submissions regulators WANT to read.
Chief Executive Officer, Large Molecule Biotech Company

Insights Hub

Sharing insights, questioning norms, asking the right questions - we'll never lose sight of what you're striving for. Our insight and expertise will help you bring the most innovative therapies within reach of patients around the world.
Placeholder Image
28.11.22
Giovanni

What a year! Biopharma Excellence has been easing the path to market for a whole host of advanced therapies and biosimilars

by Dr. Christian K Schneider Head of Biopharma Excellence   As Biopharma Excellence marks its

Start a conversation today

Socials: